XHKG
1863
Market cap148mUSD
Feb 14, Last price
1.37HKD
Name
China Longevity Group Co Ltd
Chart & performance
P/E
23.07
P/S
0.85
EPS
0.05
Div yield, %
—
Shrs. gr., 5y
—
Rev. gr., 5y
7.65%
Revenues
1.17b
+0.74%
Net income
43m
-22.25%
CFO
109m
+4.96%
Dividend
May 25, 20120.1 HKD/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
China Longevity Group operates within the reinforced materials industry, engaging comprehensively in the design, development, production, and distribution of its specialized products. These offerings include advanced polymer-processed polyester fabric composite materials, diverse reinforced composites, conventional materials, and a range of inflatable and waterproof items. The company's versatile products find widespread application across numerous sectors, such as outdoor recreation, sports, renewable energy, protective equipment, construction, transportation, packaging, medical uses, safety solutions, advertising, and everyday consumer goods. Its commercial reach extends globally, with a notable presence in China, the USA, Russia, and various other international markets.
Key people
Company Secretary, Chief Financial Officer · since 2016
Basheng Liao
General Manager and Head of Manufacturing Center of Groups Fuzhou Factory
Lijuan Zheng
Deputy General Manager, Head - Procurement Department
Juwen Gao
Executive Director · since 2022
Shisheng Jiang
Division Head - Technology, Executive Director · since 2016
Jun Liu
Executive Director · since 2021
Guangxing Chen
Vice General Manager of Sijia Industrial Material Shanghai Company Limited
Daohuo Huang
Deputy Director of the Groups Product Marketing and the Head of Production Scheduling of the Groups · since 2021
Chaoyang Zhu
Engineer of the Groups the Fuzhou Factorys Equipment Center
Ping Jiang
Independent Non-Executive Director · since 2017
Independent Non-Executive Director · since 2016
Jiayu Lu
Non-Executive Independent Director · since 2017
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||